Endocrinology · Toms River, NJ
NPI
1396719662
Since 2006
Specialty
Endocrinology
Code 174400000X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
1163 Route 37 West, Suite A-1
Toms River, NJ, 08755
Phone (732) 736-1000
Groups this clinician bills Medicare through
Medicare paid, 2024
$324K
5,113 services
Medicare patients, 2024
1,325
Average age 76
Drug cost, 2024
$5.3M
11,382 prescriptions
Company payments, 2025
$30K
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Oscar T Ortiz was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 2,001 times for 1,091 patients. In total Oscar T Ortiz billed 5,113 services in 15 codes, and Medicare paid $324K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-03-06.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 2,001 | 1,091 | $13.62 | $27K |
| 99214 Office E&M - Established | Office | 1,477 | 811 | $103.23 | $152K |
| 99213 Office E&M - Established | Office | 484 | 356 | $72.49 | $35K |
| 99215 Office E&M - Established | Office | 398 | 198 | $157.15 | $63K |
| 95251 Test - Miscellaneous | Office | 395 | 189 | $29.47 | $12K |
| 99204 Office E&M - New | Office | 154 | 154 | $137.79 | $21K |
| 99442 Telephone Services | Office | 68 | 58 | $67.54 | $4,592 |
| 82962 Clinical Chemistry | Office | 42 | 39 | $3.06 | $129 |
| 95250 Test - Miscellaneous | Office | 33 | 32 | $134.84 | $4,450 |
| 99203 Office E&M - New | Office | 28 | 28 | $87.84 | $2,459 |
| 95249 Test - Miscellaneous | Office | 25 | 24 | $61.17 | $1,529 |
By year: 2022 $314K for 5,141 services; 2023 $263K for 4,293 services; 2024 $324K for 5,113 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82962 Clinical Chemistry | 42 | 39 | $3.06 | $129 |
Medicare prescription drug claims, 2024
In 2024, the drug Oscar T Ortiz prescribed most often to Medicare patients was Levothyroxine Sodium, with 1,401 prescriptions and refills. In total Oscar T Ortiz wrote 11,382 Medicare prescriptions that cost $5.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 1,401 | 3,818 | 379 | $16K |
| Metformin Hcl Generic | 757 | 2,147 | 271 | $8,082 |
| Synthroid Levothyroxine Sodium | 732 | 2,059 | 174 | $61K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 586 | 1,631 | 264 | $72K |
| Ozempic Semaglutide | 472 | 1,023 | 154 | $933K |
| Toujeo Solostar Insulin Glargine,hum.Rec.Anlog | 430 | 1,295 | 177 | $292K |
| Metformin Hcl Er Metformin Hcl | 387 | 1,122 | 134 | $6,500 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 381 | 1,118 | 146 | $67K |
| Farxiga Dapagliflozin Propanediol | 365 | 886 | 107 | $480K |
| Humalog Kwikpen U-100 Insulin Lispro | 317 | 969 | 141 | $115K |
| Jardiance Empagliflozin | 298 | 692 | 93 | $391K |
| Glimepiride Generic | 290 | 835 | 102 | $3,888 |
| Januvia Sitagliptin Phosphate | 272 | 696 | 94 | $370K |
| Mounjaro Tirzepatide | 268 | 422 | 65 | $440K |
| Tresiba Flextouch U-100 Insulin Degludec | 180 | 528 | 66 | $172K |
Brand drugs: 6,153 claims; generic drugs: 3,903 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Oscar T Ortiz $30K ($30K in general payments such as food, travel and fees) from 7 companies. The largest payer was Lilly USA, LLC with $30K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.